About this FactMed analysis covering adverse side effect reports of ACTIT patients who developed ILEUS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 4 individuals taking ACTIT reported ILEUS to the FDA. A total of 67 ACTIT drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACTIT and ILEUS. In doing so, we compare ACTIT with other drugs that cause ILEUS, to help you evaluate whether or not ACTIT causes ILEUS. Likewise, this page shows the most highly-reported side effects of ACTIT, so you can see if ILEUS ranks among ACTIT's most well-known side effects.
Summary Statistics
Reports of ACTIT causing ILEUS: 4
Reports of any side effect of ACTIT : 67
Percentage of ACTIT patients where ILEUS is a reported side effect: 5.9701%

FDA reports of any drug causing ILEUS : 5674
Average percentage for all medicated patients where ILEUS is reported as a complication: 0.0356%

Physician opinion on ACTIT as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACTIT:
PYREXIA ( 5 patients )
INFUSION ( 4 patients )
DECREASED APPETITE ( 3 patients )
FLUID REPLACEMENT ( 2 patients )
ASTHMA ( 1 patients )
DEHYDRATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ILEUS:

ACCUTANE (522 patients)
ASPIRIN (452 patients)
HUMIRA (351 patients)
LASIX (332 patients)
FLUOROURACIL (316 patients)
PREDNISOLONE (273 patients)
REMICADE (269 patients)
ZOFRAN (230 patients)
OXALIPLATIN (216 patients)
VIOXX (214 patients)
CARBOPLATIN (213 patients)
OXYCONTIN (211 patients)
PREDNISONE (208 patients)
PROTONIX (205 patients)
NEXIUM (201 patients)
AVASTIN (193 patients)
SEROQUEL (192 patients)
FOLIC ACID (190 patients)
ZOMETA (189 patients)
FUROSEMIDE (186 patients)
CAPECITABINE (186 patients)
FOSAMAX (184 patients)
DECADRON (179 patients)
DEXAMETHASONE (174 patients)
OMEPRAZOLE (170 patients)
NORVASC (169 patients)
DURAGESIC-100 (166 patients)
PROGRAF (164 patients)
OXYCODONE HCL (162 patients)
ACETAMINOPHEN (159 patients)
VELCADE (157 patients)
NEURONTIN (154 patients)
HEPARIN SODIUM INJECTION (152 patients)
LISINOPRIL (152 patients)
CISPLATIN (151 patients)
METHOTREXATE (150 patients)
MAGNESIUM OXIDE (149 patients)
AREDIA (142 patients)
XELODA (140 patients)
ATIVAN (139 patients)
LIPITOR (137 patients)
COUMADIN (134 patients)
SYNTHROID (134 patients)
PREVACID (134 patients)
ALLOPURINOL (131 patients)
PERCOCET (130 patients)
POTASSIUM CHLORIDE (127 patients)
BEVACIZUMAB (125 patients)
PRILOSEC (125 patients)
MORPHINE (123 patients)
REGLAN (120 patients)
CYCLOPHOSPHAMIDE (119 patients)
IRINOTECAN HCL (119 patients)
ACTEMRA (115 patients)
VICODIN (114 patients)
FAMOTIDINE (113 patients)
TAXOL (111 patients)
LORAZEPAM (111 patients)
XANAX (110 patients)
LEVOTHYROXINE SODIUM (110 patients)
DOXORUBICIN HCL (110 patients)
IBUPROFEN (109 patients)
ZYPREXA (108 patients)
HEPARIN (106 patients)
LOXONIN (106 patients)
ALBUTEROL (104 patients)
ZOCOR (102 patients)
GLEEVEC (102 patients)
DIOVAN (100 patients)
SIMVASTATIN (99 patients)
COLACE (98 patients)
COMPAZINE (97 patients)
DIGOXIN (97 patients)
FENTANYL (96 patients)
LEVAQUIN (95 patients)
AMLODIPINE (94 patients)
MULTI-VITAMIN (94 patients)
LEUCOVORIN CALCIUM (94 patients)
CELEBREX (94 patients)
METOCLOPRAMIDE (94 patients)
DILAUDID (93 patients)
REVLIMID (93 patients)
PREDNISONE TAB (93 patients)
CLONAZEPAM (91 patients)
LYRICA (91 patients)
CYTARABINE (90 patients)
ATENOLOL (89 patients)
FOSRENOL (89 patients)
PACLITAXEL (89 patients)
AMBIEN (88 patients)
SPIRIVA (87 patients)
CETUXIMAB (87 patients)
HYDROCHLOROTHIAZIDE (87 patients)
RISPERDAL (87 patients)
ETOPOSIDE (86 patients)
NITROGLYCERIN (86 patients)
METFORMIN HCL (86 patients)
LANSOPRAZOLE (83 patients)
METOPROLOL TARTRATE (83 patients)
PLAVIX (82 patients)
CIPROFLOXACIN (81 patients)
GABAPENTIN (80 patients)
LANTUS (79 patients)
VINCRISTINE (78 patients)
NEORAL (78 patients)
ZITHROMAX (78 patients)
LEXAPRO (76 patients)
PAXIL (76 patients)
ZANTAC (76 patients)
SENOKOT (75 patients)
KYTRIL (74 patients)
VITAMIN B-12 (74 patients)
METRONIDAZOLE (73 patients)
PROZAC (73 patients)
VANCOMYCIN (72 patients)
LACTULOSE (72 patients)
AUGMENTIN '125' (72 patients)
PREDONINE (72 patients)
ZOLOFT (71 patients)
RENAGEL (71 patients)
MYCOPHENOLATE MOFETIL (71 patients)
VOLTAREN (71 patients)
CELEXA (70 patients)
VITAMIN D (69 patients)
ZOLPIDEM (69 patients)
WARFARIN SODIUM (68 patients)
ABILIFY (67 patients)
MORPHINE SULFATE (67 patients)
PENTASA (67 patients)
FLUCONAZOLE (66 patients)
TOCILIZUMAB (66 patients)
BENADRYL (66 patients)
CLOZAPINE (65 patients)
ALIMTA (65 patients)
ALPRAZOLAM (64 patients)
GEMCITABINE (64 patients)
KLONOPIN (64 patients)
DEPAKENE (64 patients)
VALIUM (63 patients)
^BLOOD BOTTLES^ (63 patients)
TOPROL-XL (62 patients)
TEGRETOL (62 patients)
ERYTHROMYCIN (62 patients)
BACTRIM (62 patients)
CALCIUM (61 patients)
PHENERGAN (61 patients)
SUTENT (61 patients)
CALCIUM CARBONATE (60 patients)
HALOPERIDOL (60 patients)
FLONASE (60 patients)
WELLBUTRIN (60 patients)
AMARYL (59 patients)
FLOMAX (59 patients)
EFFEXOR (59 patients)
METHYLPREDNISOLONE (59 patients)
SINGULAIR (59 patients)
JANUVIA (59 patients)
CYCLOSPORINE (58 patients)
MUCOSTA (57 patients)
RITUXIMAB (57 patients)
LOPRESSOR (57 patients)
LORTAB (56 patients)
METOPROLOL (56 patients)
PHYSIOSOL IN PLASTIC CONTAINER (56 patients)
MIRALAX (55 patients)
AMITRIPTYLINE HCL (55 patients)
PANITUMUMAB (55 patients)
ENBREL (54 patients)
FERROUS SULFATE TAB (54 patients)
TRAZODONE HCL (54 patients)
COZAAR (54 patients)
CLINDAMYCIN (54 patients)
MAGMITT (54 patients)
PEPCID (53 patients)
ONDANSETRON (53 patients)
GLUCOPHAGE (53 patients)
BACLOFEN (53 patients)
RANITIDINE (53 patients)
CLONIDINE (53 patients)
ULTRAM (52 patients)
CERTICAN (52 patients)
COREG (52 patients)
FLAGYL (52 patients)
CYMBALTA (52 patients)
TACROLIMUS (52 patients)
ARANESP (51 patients)
ADVAIR DISKUS 100/50 (51 patients)
SOLU-MEDROL (50 patients)
AMOXICILLIN (50 patients)
INSULIN (49 patients)
LOMOTIL (49 patients)
VINCRISTINE SULFATE (49 patients)
VITAMIN B6 (49 patients)
DIANEAL (49 patients)
DOCETAXEL (49 patients)
TAXOTERE (49 patients)
PANTOPRAZOLE SODIUM (48 patients)
COMBIVENT (48 patients)
NEUPOGEN (48 patients)
GASTER (48 patients)
ACTOS (48 patients)
PANTOPRAZOLE (48 patients)
TAKEPRON (48 patients)
PARACETAMOL (48 patients)
GOLIMUMAB (48 patients)
AVONEX (47 patients)
ZYRTEC (47 patients)
MEGACE (47 patients)
LOPERAMIDE (47 patients)
DOCUSATE SODIUM (47 patients)
Most common side effects for patients taking ACTIT:
BLOOD POTASSIUM DECREASED (12 patients)
DIZZINESS POSTURAL (12 patients)
MULTIPLE SCLEROSIS RELAPSE (12 patients)
PALPITATIONS (12 patients)
LIVER DISORDER (7 patients)
NAUSEA (7 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (6 patients)
PYREXIA (6 patients)
ALANINE AMINOTRANSFERASE INCREASED (5 patients)
DYSPNOEA (5 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (5 patients)
HYPERTHERMIA (5 patients)
BLOOD PRESSURE DECREASED (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
HEPATIC FUNCTION ABNORMAL (4 patients)
ILEUS (4 patients)
PNEUMONIA (4 patients)
PNEUMONIA ASPIRATION (4 patients)
STEVENS-JOHNSON SYNDROME (4 patients)
WHITE BLOOD CELL COUNT INCREASED (4 patients)
ANOREXIA NERVOSA (3 patients)
DECREASED APPETITE (3 patients)
DEPRESSION (3 patients)
DIARRHOEA (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
DYSPHORIA (3 patients)
GASTROINTESTINAL ULCER (3 patients)
HAEMATOCRIT DECREASED (3 patients)
MALAISE (3 patients)
PARKINSONISM (3 patients)
RENAL FAILURE (3 patients)
SHOCK HAEMORRHAGIC (3 patients)
SOMNOLENCE (3 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (3 patients)
VOMITING (3 patients)
ANORECTAL OPERATION (2 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (2 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BRONCHIAL HAEMORRHAGE (2 patients)
CARDIAC FAILURE (2 patients)
COLD SWEAT (2 patients)
COUGH (2 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (2 patients)
DRUG ERUPTION (2 patients)
DYSKINESIA (2 patients)
DYSURIA (2 patients)
FIBRINOLYSIS INCREASED (2 patients)
GENERALISED ERYTHEMA (2 patients)
HAEMODIALYSIS (2 patients)
HAEMORRHAGE SUBCUTANEOUS (2 patients)
HEPARIN-INDUCED THROMBOCYTOPENIA (2 patients)
HEPATITIS ACUTE (2 patients)
HEPATITIS FULMINANT (2 patients)
MELAENA (2 patients)
PAIN (2 patients)
PLATELET COUNT DECREASED (2 patients)
PLATELET COUNT INCREASED (2 patients)
PNEUMONIA BACTERIAL (2 patients)
PRODUCTIVE COUGH (2 patients)
PROTEIN TOTAL DECREASED (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE ACUTE (2 patients)
RESPIRATORY ARREST (2 patients)
THROMBOCYTOPENIA (2 patients)
URINARY TRACT INFECTION (2 patients)
WHEEZING (2 patients)
WHITE BLOOD CELL COUNT DECREASED (2 patients)
ABNORMAL BEHAVIOUR (1 patients)
ANOREXIA (1 patients)
BACK PAIN (1 patients)
BLOOD GLUCOSE INCREASED (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLOOD URINE PRESENT (1 patients)
BRADYCARDIA (1 patients)
C-REACTIVE PROTEIN INCREASED (1 patients)
CACHEXIA (1 patients)
CAESAREAN SECTION (1 patients)
CHILLS (1 patients)
CHOLANGITIS SCLEROSING (1 patients)
COAGULATION TEST ABNORMAL (1 patients)
COAGULOPATHY (1 patients)
COMA (1 patients)
CONJUNCTIVAL HYPERAEMIA (1 patients)
CONSTIPATION (1 patients)
CONVULSION (1 patients)
DEATH (1 patients)
DIZZINESS (1 patients)
DRUG EXPOSURE DURING PREGNANCY (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG INTERACTION (1 patients)
FALL (1 patients)
FEELING ABNORMAL (1 patients)
FOETAL GROWTH RETARDATION (1 patients)
FUNGAL TEST POSITIVE (1 patients)
GASTROINTESTINAL DISORDER (1 patients)
GASTROINTESTINAL HAEMORRHAGE (1 patients)
HEADACHE (1 patients)
HEPATIC NEOPLASM MALIGNANT (1 patients)
HYPERCALCAEMIA (1 patients)
HYPERKALAEMIA (1 patients)
HYPOMANIA (1 patients)
INJURY ASPHYXIATION (1 patients)
INTERSTITIAL LUNG DISEASE (1 patients)
IRRITABILITY (1 patients)
LIVER FUNCTION TEST ABNORMAL (1 patients)
LYMPHADENOPATHY (1 patients)
LYMPHOCYTE STIMULATION TEST POSITIVE (1 patients)
MALNUTRITION (1 patients)
MUSCLE RIGIDITY (1 patients)
MYDRIASIS (1 patients)
OCULOMUCOCUTANEOUS SYNDROME (1 patients)
ORGANISING PNEUMONIA (1 patients)
PLEURAL EFFUSION (1 patients)
POST PROCEDURAL COMPLICATION (1 patients)
PRE-ECLAMPSIA (1 patients)
PROCTALGIA (1 patients)
PULMONARY TUBERCULOSIS (1 patients)
RASH GENERALISED (1 patients)
RED BLOOD CELL ANISOCYTES PRESENT (1 patients)
RENAL CELL CARCINOMA (1 patients)
RESPIRATORY DISORDER (1 patients)
SEPSIS (1 patients)
SPEECH DISORDER (1 patients)
STUPOR (1 patients)
SUDDEN DEATH (1 patients)
TACHYCARDIA (1 patients)
WHITE BLOOD CELLS URINE POSITIVE (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACTIT


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ILEUS and ACTIT, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACTIT, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACTIT. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACTIT experts. If you are a healthcare provider experienced in prescribing ACTIT, please register here.
giCould not connect: